Puig M Victoria, Miller Earl K
The Picower Institute for Learning and Memory and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Cereb Cortex. 2015 Sep;25(9):2980-7. doi: 10.1093/cercor/bhu096. Epub 2014 May 9.
Dopamine D2 receptors (D2R) play a major role in cognition, mood and motor movements. Their blockade by antipsychotic drugs reduces hallucinatory and delusional behaviors in schizophrenia, but often fails to alleviate affective and cognitive dysfunctions. The prefrontal cortex (PFC) expresses D2R and is altered in schizophrenia. We investigated how D2R modulate behavior and PFC function in monkeys. Two monkeys learned new and performed highly familiar visuomotor associations, where each cue was associated with a saccade to a right or left target. We recorded neural spikes and local field potentials from multiple electrodes while injecting the D2R antagonist eticlopride in the lateral PFC. Blocking prefrontal D2R impaired associative learning and cognitive flexibility, reduced motivation, but left the performance of familiar associations intact. Eticlopride reduced saccade-direction selectivity of prefrontal neurons, leading to a decrease in neural information about the associations, and an increase in alpha oscillations. These results, together with our recent study using a D1R antagonist, suggest that D1R and D2R in the primate lateral PFC cooperate to modulate several executive functions. Our findings help to gain insight into why antipsychotic drugs, with strong antagonistic actions on D2R, fail to ameliorate cognitive and emotional deficits in schizophrenia.
多巴胺D2受体(D2R)在认知、情绪和运动行为中起主要作用。抗精神病药物对其的阻断作用可减少精神分裂症患者的幻觉和妄想行为,但往往无法缓解情感和认知功能障碍。前额叶皮质(PFC)表达D2R,且在精神分裂症中发生改变。我们研究了D2R如何调节猴子的行为和PFC功能。两只猴子学习新的并执行高度熟悉的视觉运动关联任务,其中每个提示与向右或向左目标的扫视相关联。在向外侧PFC注射D2R拮抗剂依替必利时,我们从多个电极记录神经尖峰和局部场电位。阻断前额叶D2R会损害联想学习和认知灵活性,降低动机,但不影响熟悉关联任务的表现。依替必利降低了前额叶神经元的扫视方向选择性,导致关于关联的神经信息减少,以及α振荡增加。这些结果,连同我们最近使用D1R拮抗剂的研究,表明灵长类动物外侧PFC中的D1R和D2R协同调节多种执行功能。我们的研究结果有助于深入了解为什么对D2R具有强烈拮抗作用的抗精神病药物无法改善精神分裂症患者的认知和情感缺陷。